Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Fampridine – Benefit assessment according to § 35a Social Code Book V
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.
Immune cell trafficking from the brain maintains CNS immune tolerance.
The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.
RNF and Betaseron® Tolerability Study (REFORMS)
Role of statins in the treatment of multiple sclerosis.
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: Another aspect of immune privilege in the CNS.
Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis.
NAD⁺ in aging, metabolism, and neurodegeneration.
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Pages